BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 7993838)

  • 1. On the emerging role of chemistry in the fashioning of biologics: synthesis of a bidomainal fucosyl GM1-based vaccine for the treatment of small cell lung cancer.
    Nagorny P; Kim WH; Wan Q; Lee D; Danishefsky SJ
    J Org Chem; 2009 Aug; 74(15):5157-62. PubMed ID: 19555091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New serum markers for small-cell lung cancer. I. The ganglioside fucosyl-GM1.
    Vangsted A; Drivsholm L; Andersen E; Pallesen T; Zeuthen J; Wallin H
    Cancer Detect Prev; 1994; 18(3):221-9. PubMed ID: 8076384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum immunoassay of a small cell lung cancer associated ganglioside: development of a sensitive scintillation proximity assay.
    Pallesen T; Vangsted A; Drivsholm L; Clausen H; Zeuthen J; Wallin H
    Glycoconj J; 1992 Dec; 9(6):331-5. PubMed ID: 1339041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical detection of a small cell lung cancer-associated ganglioside (FucGM1) antigen in serum.
    Vangsted AJ; Clausen H; Kjeldsen TB; White T; Sweeney B; Hakomori S; Drivsholm L; Zeuthen J
    Cancer Res; 1991 Jun; 51(11):2879-84. PubMed ID: 1851663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New serum markers for small-cell lung cancer. II. The neural cell adhesion molecule, NCAM.
    Vangsted A; Drivsholm L; Andersen E; Bock E
    Cancer Detect Prev; 1994; 18(4):291-8. PubMed ID: 7982239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fucosyl-GM1 in small-cell lung cancer. A comparison with the tumour marker neuron-specific enolase.
    Drivsholm L; Vangsted A; Pallesen T; Hansen M; Dombernowsky P; Hirsch F; Hansen HH
    Ann Oncol; 1994 Sep; 5(7):623-6. PubMed ID: 7993838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies for diagnosis and potential therapy of small cell lung cancer--the ganglioside antigen fucosyl-GM1.
    Vangsted AJ; Zeuthen J
    Acta Oncol; 1993; 32(7-8):845-51. PubMed ID: 8305235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reevaluaton of the usefulness of systematic bone scanning in initial staging and follow-up of small cell lung carcinoma, taking into account the serum levels of neuron-specific enolase.
    Gendreau V; Montravers F; Philippe C; Talbot JN
    Int J Biol Markers; 1997; 12(4):148-53. PubMed ID: 9582603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical biochemistry of neuron specific enolase.
    Kaiser E; Kuzmits R; Pregant P; Burghuber O; Worofka W
    Clin Chim Acta; 1989 Jul; 183(1):13-31. PubMed ID: 2548772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
    Isgrò MA; Bottoni P; Scatena R
    Adv Exp Med Biol; 2015; 867():125-43. PubMed ID: 26530364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Serum Neuron-Specific Enolase (NSE) Level Firstly Ignored as Normal Reaction in a Small Cell Lung Cancer Patient: a Case Report and Literature Review.
    Ge YL; Liu CH; Wang MH; Zhu XY; Zhang Q; Li ZZ; Li HL; Cui ZY; Zhang HF; Zhang X; Yu HL; Fu AS; Wang HY
    Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775876
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.